Nathan Stitziel

Medicine & Life Sciences

1. Exome 100%
2. Coronary Disease 65%
3. Coronary Artery Disease 53%
4. Genes 42%
5. Mutation 42%
6. Human Genetics 38%
7. Lipids 37%
8. Hyperlipoproteinemia Type II 35%
9. Alleles 31%
10. Single Nucleotide Polymorphism 28%
11. Genome 28%
12. LDL Cholesterol 27%
13. Loss of Function Mutation 23%
14. Cardiovascular Diseases 23%
15. HDL Cholesterol 20%
16. Angiopoietins 20%
17. Genetic Association Studies 19%
18. Atherosclerosis 19%
19. Whole Genome Sequencing 19%
20. Inborn Genetic Diseases 19%
21. Protein-Lysine 6-Oxidase 18%
22. Triglycerides 18%
23. High-Protein Diet 18%
24. Lipidomics 17%
25. Mitochondrial Genome 16%
26. Genome-Wide Association Study 16%
27. Myocardial Infarction 16%
28. DNA Sequence Analysis 15%
29. Lipoprotein(a) 14%
30. Hydroxymethylglutaryl-CoA Reductase Inhibitors 13%
31. Genetic Variation 13%
32. Primary Prevention 13%
33. Cholesterol 13%
34. Thoracic Aortic Aneurysm 13%
35. LDL Receptors 12%
36. Lipoproteins 12%
37. Autosomal Recessive Hypercholesterolemia 12%
38. Population 12%
39. Odds Ratio 11%
40. Cholesterol Ester Storage Disease 11%
41. Aortic Diseases 11%
42. Meta-Analysis 11%
43. Crowdsourcing 10%
44. Lipoprotein Lipase 10%
45. Genotype 9%
46. 1-Alkyl-2-acetylglycerophosphocholine Esterase 9%
47. Oculomelic amyoplasia 9%
48. Whole Exome Sequencing 9%
49. Apolipoproteins 9%
50. Type 2 Diabetes Mellitus 9%